241 related articles for article (PubMed ID: 28757384)
1. ZNF509S1 downregulates PUMA by inhibiting p53K382 acetylation and p53-DNA binding.
Jeon BN; Yoon JH; Han D; Kim MK; Kim Y; Choi SH; Song J; Kim KS; Kim K; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):962-972. PubMed ID: 28757384
[TBL] [Abstract][Full Text] [Related]
2. Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating transcription of p21/CDKN1A and RB upon exposure to genotoxic stress.
Jeon BN; Kim MK; Yoon JH; Kim MY; An H; Noh HJ; Choi WI; Koh DI; Hur MW
Nucleic Acids Res; 2014 Oct; 42(18):11447-61. PubMed ID: 25245946
[TBL] [Abstract][Full Text] [Related]
3. KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes.
Koh DI; Han D; Ryu H; Choi WI; Jeon BN; Kim MK; Kim Y; Kim JY; Parry L; Clarke AR; Reynolds AB; Hur MW
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15078-83. PubMed ID: 25288747
[TBL] [Abstract][Full Text] [Related]
4. SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity.
Mizuguchi Y; Specht S; Lunz JG; Isse K; Corbitt N; Takizawa T; Demetris AJ
BMC Mol Biol; 2012 Jun; 13():20. PubMed ID: 22731250
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.
Kim MK; Jeon BN; Koh DI; Kim KS; Park SY; Yun CO; Hur MW
J Biol Chem; 2013 Mar; 288(10):7053-64. PubMed ID: 23329847
[TBL] [Abstract][Full Text] [Related]
6. Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element.
Sinha S; Malonia SK; Mittal SP; Singh K; Kadreppa S; Kamat R; Mukhopadhyaya R; Pal JK; Chattopadhyay S
EMBO J; 2010 Feb; 29(4):830-42. PubMed ID: 20075864
[TBL] [Abstract][Full Text] [Related]
7. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
8. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
Puca R; Nardinocchi L; Sacchi A; Rechavi G; Givol D; D'Orazi G
Mol Cancer; 2009 Oct; 8():85. PubMed ID: 19828042
[TBL] [Abstract][Full Text] [Related]
9. Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons.
Brochier C; Dennis G; Rivieccio MA; McLaughlin K; Coppola G; Ratan RR; Langley B
J Neurosci; 2013 May; 33(20):8621-32. PubMed ID: 23678107
[TBL] [Abstract][Full Text] [Related]
10. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
11. p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG.
Thakur VS; Ruhul Amin AR; Paul RK; Gupta K; Hastak K; Agarwal MK; Jackson MW; Wald DN; Mukhtar H; Agarwal ML
Cancer Lett; 2010 Oct; 296(2):225-32. PubMed ID: 20444544
[TBL] [Abstract][Full Text] [Related]
12. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.
Dornan D; Eckert M; Wallace M; Shimizu H; Ramsay E; Hupp TR; Ball KL
Mol Cell Biol; 2004 Nov; 24(22):10083-98. PubMed ID: 15509808
[TBL] [Abstract][Full Text] [Related]
14. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
[TBL] [Abstract][Full Text] [Related]
15. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.
Tang Y; Luo J; Zhang W; Gu W
Mol Cell; 2006 Dec; 24(6):827-39. PubMed ID: 17189186
[TBL] [Abstract][Full Text] [Related]
16. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
17. Methylation-acetylation interplay activates p53 in response to DNA damage.
Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
[TBL] [Abstract][Full Text] [Related]
18. Chromium-mediated apoptosis: involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes.
Hill R; Leidal AM; Madureira PA; Gillis LD; Waisman DM; Chiu A; Lee PW
DNA Repair (Amst); 2008 Sep; 7(9):1484-99. PubMed ID: 18602874
[TBL] [Abstract][Full Text] [Related]
19. Human EHMT2/G9a activates p53 through methylation-independent mechanism.
Rada M; Vasileva E; Lezina L; Marouco D; Antonov AV; Macip S; Melino G; Barlev NA
Oncogene; 2017 Feb; 36(7):922-932. PubMed ID: 27452519
[TBL] [Abstract][Full Text] [Related]
20. HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53.
Sasaki T; Gan EC; Wakeham A; Kornbluth S; Mak TW; Okada H
Genes Dev; 2007 Apr; 21(7):848-61. PubMed ID: 17403783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
